<?xml version="1.0" encoding="UTF-8"?>
<ref id="B128-materials-13-04532">
 <label>128.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Andrade</surname>
    <given-names>E.L.</given-names>
   </name>
   <name>
    <surname>Bento</surname>
    <given-names>A.F.</given-names>
   </name>
   <name>
    <surname>Cavalli</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Oliveira</surname>
    <given-names>S.K.</given-names>
   </name>
   <name>
    <surname>Freitas</surname>
    <given-names>C.S.</given-names>
   </name>
   <name>
    <surname>Marcon</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Schwanke</surname>
    <given-names>R.C.</given-names>
   </name>
   <name>
    <surname>Siqueira</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Calixto</surname>
    <given-names>J.B.</given-names>
   </name>
  </person-group>
  <article-title>Non-Clinical Studies Required for New Drug Developmentâ€”Part I: Early in Silico and in Vitro Studies, New Target Discovery and Validation, Proof of Principles and Robustness of Animal Studies</article-title>
  <source>Braz. J. Med. Biol. Res.</source>
  <year>2016</year>
  <volume>49</volume>
  <fpage>e5644</fpage>
  <pub-id pub-id-type="doi">10.1590/1414-431x20165644</pub-id>
  <pub-id pub-id-type="pmid">27783811</pub-id>
 </element-citation>
</ref>
